Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1971 Sep;30(5):501–505. doi: 10.1136/ard.30.5.501

Non-thrombocytopenic purpura and acute glomerulonephritis after indomethacin therapy.

F P Marsh, J R Almeyda, I S Levy
PMCID: PMC1005815  PMID: 4106997

Full text

PDF

Images in this article

501Image
on p.501
502Image
on p.502
503Image
on p.503
503Image
on p.503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALLABIO C. B., GIRARDI G., CARUSO I., CIRLA E., COLOMBO B. EFFETTI CLINICI E METABOLICI DELL'INDOMETHACIN NELLE MALATTIE REUMATICHE. Reumatismo. 1963 Nov-Dec;15:487–499. [PubMed] [Google Scholar]
  2. BRUCKNER F. E., RANDLE A. P. THE USE OF INDOMETHACIN IN RHEUMATOID ARTHRITIS. Ann Phys Med. 1965 Aug;8:100–102. doi: 10.1093/rheumatology/8.3.100. [DOI] [PubMed] [Google Scholar]
  3. BYWATERS E. G., ISDALE I., KEMPTON J. J. Schönlein-Henoch purpura; evidence for a group A beta-haemolytic streptococcal aetiology. Q J Med. 1957 Apr;26(102):161–175. [PubMed] [Google Scholar]
  4. Boardman P. L., Hart F. D. Side-effects of indomethacin. Ann Rheum Dis. 1967 Mar;26(2):127–132. doi: 10.1136/ard.26.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LEE J. C., DUSHKIN M., EYRING E. J., ENGLEMAN E. P., HOPPER J., Jr RENAL LESIONS ASSOCIATED WITH GOLD THERAPY; LIGHT AND ELECTRON MICROSCOPIC STUDIES. Arthritis Rheum. 1965 Feb;8:1–13. doi: 10.1002/art.1780080102. [DOI] [PubMed] [Google Scholar]
  6. Lancaster-Smith M. J. Delayed reaction to phenindione. Lancet. 1969 Nov 8;2(7628):1011–1011. doi: 10.1016/s0140-6736(69)90569-8. [DOI] [PubMed] [Google Scholar]
  7. MICHOTTE L. J., WAUTERS M. CLINICAL TEST OF INDOMETHACIN. Acta Rheumatol Scand. 1964;10:273–280. doi: 10.3109/rhe1.1964.10.issue-1-4.31. [DOI] [PubMed] [Google Scholar]
  8. Meyer E., Schoenfeld L. S. L'indométhacine dans le traitement des maladies rhumatismales. Schweiz Med Wochenschr. 1965 Dec 11;95(50):1722–1724. [PubMed] [Google Scholar]
  9. Michielsen P., Verberckmoes R., Desmet V., Hermerijckx W. Evolution histologique des glomérulonéphrites prolifératives diffuses traitées par l'indométhacine. J Urol Nephrol (Paris) 1969 Apr-May;75(4):315–318. [PubMed] [Google Scholar]
  10. Reynolds R. D., Simerville J. J., O'Hara D. D., Hart J. B., Parkinson J. E. Hemorrhagic cystitis due to cyclophosphamide. J Urol. 1969 Jan;101(1):45–47. doi: 10.1016/s0022-5347(17)62268-7. [DOI] [PubMed] [Google Scholar]
  11. Rothermich N. O. An extended study of indomethacin. I. Clinical pharmacology. JAMA. 1966 Feb 14;195(7):531–536. [PubMed] [Google Scholar]
  12. Stoeber E., Sänger L., Kölle G. Indometacin-Behandlung der juvenilen rheumatoiden Arthritis (chronische Polyarthritis) Munch Med Wochenschr. 1968 Mar 1;110(9):548–551. [PubMed] [Google Scholar]
  13. THOMPSON M. LE MODE D'EMPLOI DE L'INDOM'ETHACINE DANS LE TRAITEMENT DES MALADIES RHUMATISMALES. Rhumatologie. 1964 Nov;16:439–440. [PubMed] [Google Scholar]
  14. VERNIER R. L., WORTHEN H. G., PETERSON R. D., COLLE E., GOOD R. A. Anaphylactoid purpura. I. Pathology of the skin and kidney and frequency of streptococcal infection. Pediatrics. 1961 Feb;27:181–193. [PubMed] [Google Scholar]
  15. Wannamaker L. W. Differences between streptococcal infections of the throat and of the skin (second of two parts). N Engl J Med. 1970 Jan 8;282(2):78–85. doi: 10.1056/NEJM197001082820206. [DOI] [PubMed] [Google Scholar]
  16. Wilkinson R., Eccleston D. W. Nephrotic syndrome induced by gold therapy. Br Med J. 1970 Jun 27;2(5712):772–772. doi: 10.1136/bmj.2.5712.772. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES